French Gene & Cell Therapy Trials To Get Own Fast-Track Approval Process
Experimental gene and cell therapy products are to get a boost from the French regulator in the form of a new fast-track clinical trial approval process. This is the third accelerated pathway to be introduced as part of efforts to speed up patient access to new medicines.
You may also be interested in...
Updated guidance on France’s experimental fast-track procedure for approving clinical trials shows that the pathway has entered a new phase.
Sponsors are being invited to trial a new fast-track system for authorizing clinical trials as part of French preparations for the new EU trial rules that are set to come into force in 2020.
A French government/industry discussion forum has come up with concrete plans for accelerating access to innovative medicines by streamlining clinical trial approval and price negotiations.